RWE Strategy Lead, Developed Brands

UCB Inc.; Boston (MA); Hybrid; USD 202,000 - 266,000; Full time

Job summary

UCB Inc. in Cambridge, MA; Raleigh, NC; or Atlanta, GA is seeking a senior RWE Strategy Lead Developed Brands in Immunology. The hybrid role requires 40% on-site work with 5-10% travel domestically and internationally.

Lead global RWE strategies to inform regulatory, reimbursement, and business decisions while collaborating with HEOR, Medical Affairs, and Data & Analytics teams. You will shape evidence-generation plans, mentor RWE talent, and advance technologies to improve patient access and

Qualifications

• Master's/PhD/MD or equivalent in Epidemiology, Public Health, HEOR, Biostatistics, Life Sciences, or related.
• 8+ years in pharma/biotech/healthcare with evidence-generation, regulatory, payer initiatives.
• Strong understanding of RWE, epidemiology, outcomes research, and healthcare data sources.
• Experience leading complex, matrixed initiatives and influencing stakeholders.

Responsibilities

• Develop and lead integrated RWE, epidemiology, outcomes research, and data strategies across the product lifecycle.
• Identify evidence gaps and define plans addressing regulatory, market access, reimbursement, safety, and patient-centered needs.
• Shape evidence-generation strategies using real-world data, registries, external controls, and innovative designs.

Skills

RWE strategy

Stakeholder influence

Project leadership

Data & analytics

AI methods

Education

Master's/PhD/MD in Epidemiology or HEOR

Job description

Make your mark for patients

We are looking for a RWE Strategy Lead Developed Brands, Immunology who is collaborative, solutions-oriented, and passionate about leveraging real world data to improve the patient experience to join our HTA and Payer Team. This role can based in Cambridge, Massachusetts, Raleigh, North Carolina, or in Atlanta, Georgia. This hybrid role requires a minimum of 40% on-site presence and 5-10% domestic and international travel.

About the Role

You will lead the development and execution of global real-world evidence (RWE) strategies that support the value, safety, effectiveness, and patient impact of UCB's therapies. You will identify critical evidence needs for existing product lifecycle and translate them into further integrated RWE, epidemiology, outcomes research, and data strategies that inform regulatory, market access, reimbursement, and business decisions, while supporting and expanding our patient access reach. This strategic leadership role requires a deep understanding of evidence generation, healthcare data, and the evolving external landscape. You will drive the use of innovative study designs, registries, real-world data sources, and emerging technologies to address key evidence gaps and ensure decision-makers have the insights needed to improve outcomes for patients. Success in this role requires scientific expertise, strategic thinking, and the ability to influence complex evidence agendas while balancing diverse stakeholder needs and long-term business priorities.

Who you'll work with

Internally, you will work with colleagues across Real World Evidence, Medical Affairs, Clinical Development, Pharmacovigilance, HEOR, Market Access, Safety, Epidemiology, Patient Impact, and Data & Analytics functions to shape evidence strategies, identify evidence gaps, and generate insights that support and defend , reimbursement, and business decisions.

Externally, you will work with academic researchers, healthcare data providers, registry organizations, contract research organizations (CROs), scientific experts, and industry stakeholders to advance evidence-generation initiatives, access relevant data sources, and ensure the delivery of high-quality, decision-grade evidence.

What you'll do

• Develop and co lead integrated real-world evidence (RWE), epidemiology, outcomes research, and data strategies that support UCB's assets across the product lifecycle.
• Identify evidence gaps and define research plans that address regulatory, market access, reimbursement, safety, and patient-centered evidence needs.
• Shape evidence-generation strategies using real-world data, registries, external control arms, innovative study designs, and other fit-for-purpose methodologies.
• Anticipate evolving scientific, regulatory, and business challenges and translate them into actionable evidence solutions and investments.
• Oversee the execution of RWE studies and programs, ensuring delivery on time, within budget, and in accordance with quality and governance standards.
• Drive alignment across complex evidence-generation activities, balancing the needs of multiple stakeholders while maximizing impact and efficiency.
• Provide strategic guidance on topics including disease burden, natural history, comparative effectiveness, long-term outcomes, drug utilization, safety commitments, and health technology assessment requirements.
• Leverage emerging technologies, including AI-enabled approaches, to enhance data strategy, evidence generation, and decision-making.
• Mentor and develop RWE talent while contributing to the continued growth of evidence-generation capabilities across the broader organization.
• Represent UCB externally through engagement with scientific experts, research partners, and industry initiatives to advance the use and impact of real-world evidence.

Interested? For this role we're looking for the following education, experience and skills

Minimum Experience/Skills Required

• Master's degree, PhD, MD, or equivalent advanced degree in Epidemiology, Public Health, Health Economics & Outcomes Research (HEOR), Biostatistics, Life Sciences, or a related discipline.
• 8+ years of experience within the pharmaceutical, biotechnology, healthcare, or academic sectors with demonstrated involvement in evidence generation, clinical development, market access, regulatory, and/or payer-related initiatives. Experience with Big Data and AI is an advantage
• Strong understanding of real-world evidence (RWE), epidemiology, outcomes research, and healthcare data sources.
• Experience developing evidence strategies that support regulatory, reimbursement, clinical, and business decision-making.
• Demonstrated ability to lead complex initiatives and influence stakeholders in a matrix environment.

Preferred Qualifications

• Formal training in epidemiological research methods, outcomes research, health economics, or related quantitative disciplines.
• Experience developing and executing integrated RWE strategies for or with pharmaceutical assets across multiple stages of the product lifecycle.
• Prior leadership experience, including mentoring, coaching, and developing individuals or leading cross-functional teams.
• Expertise supporting health authority, payer, HTA, or market access interactions through evidence generation.
• Experience in Immunology, Dermatology, Respiratory, or other specialty therapeutic areas.
• Familiarity with innovative study designs, registries, external data sources, AI-enabled technologies, and advanced evidence-generation methodologies.

The reasonably anticipated salary range for this position is $202,400 - $265,700 per year. The actual salary offered will take into account related knowledge, skills, experience and location among other factors and may fall outside the expected range.

About us

UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe, inspired by patients and driven by science.

Why work with us?

At UCB, we don't just complete tasks, we create value. We aren't afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We 'go beyond' to create value for our patients, and always with a human focus, whether that's on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.

At UCB, we've embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless explicitly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.

UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable federal, state, or local law. UCB invites you to voluntarily self-identify during the application process. Provision of self-identification information is entirely voluntary and a decision to provide or not provide such information will not have any effect on your application for employment, your employment with UCB, or otherwise subject you to any adverse treatment. Any information you provide will be considered confidential and will be kept separate from your application and/or personnel file and will only be used in accordance with applicable laws, orders, and regulations.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on [e-mail] for application to US based roles. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.